elective surgery days after myocardial infarction: clinical and ethical considerations
TRANSCRIPT
Case report
Elective surgery days after myocardial infarction: clinicaland ethical considerations
Pei-Lee Ee MD (Resident), Paul M. Kempen MD, PhD (Associate Professor)*
Department of Anesthesiology, University of Pittsburgh Medical Center, Presbyterian University Hospital,
Pittsburgh, PA 15213, USA
Received 4 February 2005; accepted 7 December 2005
0952-8180/$ – see front matter D 2006
doi:10.1016/j.jclinane.2005.12.002
* Corresponding author. Tel.: +1 412
E-mail address: [email protected]
Keywords:Ethics;
Myocardial infarction;
Perioperative b-blockade;Guidelines;
Cardiac;
Anesthesia;
Complication
Abstract We present an unusual case of verified myocardial infarction without surgery. Successful
elective lumbar spine surgery was performed 4 days post–myocardial infarction during perioperative
b-blockade, after cardiology evaluation recommended surgery without further evaluation. Clinical and
ethical considerations are discussed.
D 2006 Elsevier Inc. All rights reserved.
1. Introduction
Preoperative coronary events including new ischemia,
infarction, or revascularization introduce a high- and
intermediate-risk period of 4 to 6 weeks and 3 months,
respectively [1]. The generally accepted ACC/AHA guide-
lines specify recent myocardial infarction (MI) within the
past month to represent a major predictor of perioperative
risk. Current recommendations defer elective procedures
during these periods because of the associated increased
risk. Although perioperative MI is a well-described
complication with significant morbidity/mortality, MI sec-
ondary to anesthesia induction alone is not. For the first
time, the clinical course of a 57-year-old woman is
presented who (1) experienced severe ischemic electrocar-
diographic (ECG) changes upon anesthetic induction; (2)
was diagnosed with extensive non–ST-elevation myocardial
Elsevier Inc. All rights reserved.
647 5909; fax: +1 412 647 0342.
pmc.edu (P.M. Kempen).
infarction (NSTEMI) within 24 hours of anesthesia without
surgery; and (3) after extensive cardiac evaluation confirm-
ing acute infarction and minimal hemodynamic compro-
mise, was referred for immediate elective surgery 4 days
post-MI during perioperative b-blockade and aspirin
therapy. The specific factors leading to surgery immediately
postinfarction, as well as the implications and consider-
ations in performing elective surgery after such a short
interval, are presented.
2. Case report
A 57-year-old woman with back pain of 2 years’
duration, presented for a reexploration and L5-S1 micro-
discectomy. Medical history was significant for a 45 pack-
year smoking history, hypertension, hyperlipidemia, and
gastroesophageal reflux disease. Medications include hy-
drochlorothiazide, atorvastatin, estradiol, paroxetine, ome-
prazole, clonazepam, and hydrocortisone. Her physical
examination was unremarkable, including heart rate of
Journal of Clinical Anesthesia (2006) 18, 363–366
P.-L. Ee, P.M. Kempen364
80 beats per minute (bpm), blood pressure of 136/84 mmHg,
and room air oxygen saturation of 99%. Laboratory analysis
and a preoperative ECG were within normal limits.
After sedation with fentanyl 100 lg and midazolam
2 mg, rapid-sequence induction using propofol 150 mg and
succinylcholine 120 mg was instituted, followed by
rocuronium 20 mg, desflurane 2%, and 50% nitrous
oxide/oxygen. While preparing for prone positioning,
ventricular bigeminy, significant ST-segment elevation in
both monitored leads II and V, blood pressure of 210/134,
and a heart rate of 130 bpm were noted. While intravenous
metoprolol administration rapidly resolved all abnormali-
ties, surgery was deferred pending cardiac evaluation. The
patient was transferred to the postanesthesia care unit
maintaining propofol sedation until residual muscle relax-
ant effects dissipated. An ECG was now obtained
demonstrating no changes from preoperative baseline, and
cardiology consultation recommending extubation and
transfer to a monitored floor occurred. The patient
remained stable. The troponin I/creatine kinase–MB levels
were found to be 4.84 ng/mL (normal value 0.08 ng/mL)
and 10.4 ng/mL (normal b7 ng/ml if CPK b200 IU/L,
which it was at 106 IU/L) the next morning. These
represented the peak detected levels, declining to 2.54
and 8.9 ng/mL, respectively, 6.5 hours later. Repeat
ECG obtained 4 hours after the initial abnormal troponin
level was detected demonstrated sinus rhythm with T-wave
inversion in leads II, III, aVF, and V3 through V6.
Anterolateral and inferior NSTEMI was diagnosed. Ther-
apy including aspirin, intravenous heparin, and metoprolol
was instituted. A left heart catheterization performed the
next day showed no significant disease throughout the left
coronary artery. The right coronary artery was dominant,
with mild diffuse disease. Left ventriculography showed
anterior and apical wall hypokinesis and ejection fraction
(EF) of 45% to 50%. An adenosine thallium stress test
to differentiate NSTEMI vs a reversible ischemic troponin
leak was obtained, demonstrating anteroapical subendocar-
dial infarction without redistribution abnormalities. Cardi-
ology consultants specifically recommended: bPatient may
go to surgery without further testing, when surgeons are
ready, tomorrow if scheduled.Q No specific postoperative
restrictions, additional use of nonstandard intraoperative
monitors, or significant perioperative risk delineation was
suggested as (1) no significant fixed vascular lesions were
noted; (2) overall myocardial function was preserved;
(3) no transmural lesion was identified; (4) no arrhythmia
had been noted on continuous ECG monitoring, while
provocative testing for vasospasm was undesirable in the
face of acute MI; and 5) no statistical data were available
or offered regarding perioperative morbidity/mortality
in this previously unreported situation. The patient’s
metoprolol had been increased on day 3 due to tachycardia
noted on ECG and to provide effective perioperative
b-blockade along with low-dose aspirin. Smoking cessation
was instituted.
Now 3 days post-MI, troponin I level was last noted to
be abnormal and declining to 0.17 ng/mL, as was expected
to be with a singular event occurring within 24 hours of
anesthetic induction. After review of her chart, an
extended discussion with the patient occurred. She was
informed of the pertinent risks of proceeding at this time,
including death and reinfarction, with specific emphasis
that national ACC/AHA guidelines recommend to defer
surgery at least 6 weeks. The patient insisted on pro-
ceeding with her elective surgery at this time because
she had been cleared by the cardiologists, surgery was
scheduled, she had made significant efforts to dedicate
this period for surgery, and she had significant, unrelent-
ing pain. Standard consent forms and an additional note
signed by the patient and providers were placed in the
chart documenting these discussions, anesthetic recom-
mendations against surgery, and also the patient’s ulti-
mate decision.
Immediately preoperatively, the patient’s heart rate was
acutely reduced from 85 to 70 bpm with additional
titration of 12.5 mg IV metoprolol. General anesthesia
was induced using IV etomidate 22 mg with additional
8 mg before intubation. Muscle relaxation was provided by
vecuronium one mg (priming) plus 7 mg. She also
received fentanyl 50 lg. A noticeably slow onset of action
was evident for etomidate. Following the etomidate with
15 mL of saline flush, the patient remained conscious for
approximately 30 seconds. Subsequently, vecuronium
relaxation occurred after 4 minutes, in spite of a priming
dose of one mg 2 to 4 minutes before the etomidate. This
led to an additional etomidate 8 mg IV dose in anticipation
of possibly significant emergence from the original
induction dose at intubation. Isoflurane and 50% nitrous
oxide in oxygen were administered to maintain anesthesia.
An arterial catheter was placed after the slow onset of
agents and a trend toward hypotension became evident.
Intracardiac catheterization and transesophageal echocardi-
ography were not used because of risk/benefit consider-
ations and stabile overall hemodynamics persisting after
prone positioning. After prone positioning, the patient
required a phenylephrine infusion between 0.2 and
0.5 lg/kg per minute to maintain adequate mean arterial
blood pressure at 90 to 100/55 mmHg to 65 mmHg and
with heart rate at 60 F 5 bpm throughout. Glycopyrrolate
0.2 mg was administered in 0.1 doses to raise the heart
rate to 65 from 55 bpm to minimize the need for increased
phenylephrine administration. Intravenous morphine was
administered anticipating the end of surgery and postop-
erative pain. The patient was extubated immediately at the
end of the procedure without complication. No ECG
changes were noted intraoperatively in leads II or V. A
postoperative 12-lead ECG showed sinus rhythm at
62 bpm, unchanged from preoperative levels. Troponin
levels were not obtained postoperatively. The patient was
observed overnight and discharged home the next day
without further complications, per recommendations of the
Elective surgery days after myocardial infarction: clinical and ethical considerations 365
neurosurgical and cardiac services, to the care of her
family in a community with a university hospital.
3. Discussion
In the past 2 decades, improvements in cardiac manage-
ment have decreased the recommended waiting period after
MI for noncardiac surgery from 6 months to as little as
4 weeks in selected patients after minimal infarction,
without residual angina and exhibiting good functional
status. Patients with major risk factors include those with
recent MI (b4-6 weeks), unstable or severe angina (class III-
IV), ongoing ischemia after MI, congestive heart failure, or
malignant arrhythmias [1]. These patients with such major
risk factors may have as high as a 5-fold increased
perioperative risk [1]. A patient with a large infarction,
residual symptoms, and an EF below 35% has a high
probability for further cardiac events, even 6 months after
the infarction [1]. As such, the risk after previous infarction
may be related less to the age of the infarction than to
ventricular function and the amount of myocardium at risk
of further ischemia [1]. Our patient was deemed by the
cardiac consultants to be a low risk for further events during
b-blockade.Caring for patients with significant cardiovascular
disease is ubiquitous in modern anesthesia practice. Special-
ists are consulted for cardiac evaluation and to facilitate the
determination of operative readiness [2]. Research focuses
on preoperative evaluation with risk stratification of
patients, so that morbidity and mortality can be minimized,
as a member of a group, rather than as an individual [3]. Our
patient was uniquely referred as optimal for surgery
immediately post-MI and in apparent conflict with recom-
mended guidelines. In spite of specific cardiologist involve-
ment and recommendation for perioperative b-blockade,effective blockade with depression of heart rate into the
60 bpm range at rest did not occur until last-minute, and may
have significantly reduced inotropy in this setting [4,5]. The
anesthesiologist still must ultimately make specific recom-
mendations regarding anesthetic risk in consideration of
published guidelines, known risk/benefit ratios, and the
patient’s best interests. However, the risk is not always
clearly quantifiable. Risk belongs to the patient alone. After
informed consent is provided, ethical considerations place
the patient’s wishes paramount (Guidelines for the ethical
practice of anesthesiology. American Society of Anesthesi-
ologists House of Delegates, October 2003. http://www.
asahq.org/publicationsAndServices/standards/10.pdf).
This patient was extensively evaluated, informed, and
optimized for surgery by multiple consultants in a tertiary
care center, who advised the patient to proceed with surgery,
with the exception of the anesthesiologist. With the patient’s
desire to proceed immediately and with presentation of
specific and directly opposing recommendations by the
anesthesia providers, ethical guidelines take precedence [6].
Meeting the patient for the first time only immediately
before the scheduled surgery, one can only with great
difficulty establish an interpersonal rapport with the patient,
which might dissuade the patient from proceeding with
surgery, brecommendedQ by the already familiar surgeon and
cardiac consultants. It is not in the patient’s best interests to
bbe placed in the middleQ of a difference of specialists’
opinions. However, clear provision of available pertinent
dissenting information in an honest, nonthreatening, and
noncoercive manner becomes basic to the ethical process of
informed consent. Presentation of general guidelines may
ineffectively sway a patient away from recommendations to
proceed based on their personal physiology, obtained over
days and interpreted by familiar cardiac specialists in a
positive fashion. Finally, as a senior university-based
anesthesiologist, further referral or provision of substitute
providers (ie, alternate, more eager, or bbetterQ providers)
rapidly become nonoptions at the start of a busy surgical day
and in spite of any personal trepidation.
However, and in retrospect, several considerations deserve
mention and support adherence to prevailing guidelines and
in spite of the positive outcome. Although the EF was
described on ventriculogram as 45% to 50% early post-MI,
considerable b-blockade was introduced subsequently and
immediately preoperatively, which may have further com-
promised hemodynamics below previously determined val-
ues. The circulation time appeared significantly prolonged
beyond expectations at induction and blood pressure support
was required intraoperatively. Although an unusual step,
repeat examination using echocardiography immediately
preoperatively might have disclosed significant additional
interval compromise. This was not considered and knowl-
edge of these effects might have altered consultant recom-
mendations, patient decision, and anesthetic plans, resulting
in postponement of operation. The apparent signs of cardiac
depression noted only intraoperatively may have been due to
invalid interpretations of individual preoperative studies, the
increase in interval b-blockade, natural history of the
infarction, or a combination of these factors.
The absence of significant coronary stenosis or ischemia
detected in vessels supplying the antero-apical-inferior wall
(site of infarction) via angiogram or single-photon emission
computed tomography scan also raised questions regarding
validity of individual study results vs vasospasm, transient
ischemic acute coronary syndrome, or simply extreme
hypertensive tachycardia, as specific causative mechanisms
of subendocardial myonecrosis. Although calcium channel
blockers may have been more specific than b-blockers in
treating vasospasm, the strong, specific indication for
perioperative b-blockade prevailed [7,8]. Aspirin therapy
was specifically maintained perioperatively without signif-
icant detriment to hemostasis. Anesthetic care typically is
terminated upon discharge from the PACU and the decision
to discharge the patient remains the prerogative of the
surgeon and his postoperative medical consultants. With a
benign postoperative course, discharge the next morning
P.-L. Ee, P.M. Kempen366
followed typical surgical patterns and preoperative cardiac
recommendations, which imposed no restrictions. Standard
care in this unusual patient reflected the modern paradigm
for cost containment and using confirmed ongoing family
support in a community with immediate tertiary care access.
We describe for the first time successful elective micro-
discectomy 4 days post-MI, with unique preoperative
evaluation/preparation and imposing ethical factors. This
is the first report of a confirmed perianesthetic NSTEMI in
the absence of fixed coronary stenosis, proceeding to
surgery after a 4-day interval, without incident.
References
[1] Chassot PG, Delabays A, Spahn DR. Preoperative evaluation of
patients with, or at risk of, coronary artery disease undergoing non-
cardiac surgery. Br J Anaesth 2002;89:747-59.
[2] Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for
perioperative cardiovascular evaluation for noncardiac surgery—
executive summary. A report of the American College of Cardiology/
American Heart Association Task Force on practice guidelines.
Circulation 2002;105:1257-67.
[3] Tuman KJ. Perioperative cardiovascular risk: assessment and manage-
ment. Anesth Analg 2001;92:S106-12 [level V].
[4] Kertai MD, Bax JJ, Klein J, Poldermans D. Is there any reason to
withhold beta blockers from high risk patients with coronary artery
disease during surgery? Anesthesiology 2004;100:4 -7.
[5] Kempen PM. Why should primary care physicians even wait for
surgery in high risk patients? Anesthesiology 2004;101:801 -2.
[6] Whitney SN, McGuire AL, McCullough LB. A typology of shared
decision making, informed consent, and simple consent. Ann Intern
Med 2004;140:54 -9.
[7] Lee TH. Reducing cardiac risk in noncardiac surgery. N Engl J Med
1999;341:1838 -40.
[8] Lindenauer PK, Pekow P, Wang K, Mamidi D, Gutierrez B, Benjamin
EM. Perioperative beta-blocker therapy and mortality after major
noncardiac surgery. N Engl J Med 2005;353:349 -61.